NCT05172323

Brief Summary

Even with second generation drug eluting stents, rates of target lesion failure (TLF) for aorto-ostial RCA lesions remain high \[3yrs TLF 14.2%\]. Retrospective studies show that stent underexpansion and geographical stent-ostium mismatch are the main predictors for TLF. Geographical mismatch means that the stent is implanted either too distal (thereby not fully covering the lesion) or too proximal (thereby protruding too much in the aorta and hampering future engagement with guiding catheters). The investigators hypothesize that, pre-procedural 3D CT coronarography to determine the optimal C-arm angle of the X-ray system with the most accurate visualization of the aorto-ostial angle and determination of localization of calcium, could prevent geographical mismatch.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 29, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

January 13, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2023

Completed
Last Updated

March 29, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

November 24, 2021

Last Update Submit

March 27, 2023

Conditions

Keywords

Right coronary arteryComputed tomography

Outcome Measures

Primary Outcomes (1)

  • Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)

    Distance between the aorta-ostial junction and the most proximal protruding stent strut (in mm).

    Procedural

Secondary Outcomes (11)

  • Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)

    Procedural

  • Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)

    Procedural

  • Volume of contrast agent administered

    Procedural

  • Procedural radiation dose

    Procedural

  • Procedural duration from first puncture of artery to skin closure

    Procedural

  • +6 more secondary outcomes

Study Arms (2)

3DCT-guided group

EXPERIMENTAL

PCI guided with 3DCT results and IVUS

Device: 3DCT-scan

Angiography-guided group

PLACEBO COMPARATOR

PCI guided by operator and IVUS

Other: Angiography guided PCI

Interventions

3DCT-scanDEVICE

A contrast CT-scan of the coronary arteries will be performed and 3D analyzed to determine the best angle for the C-arm during Percutaneous Coronary Intervention (PCI) for stent implantation. Furthermore determining the amount and localization of calcium in the right coronary artery (RCA) and diameter and length of RCA. The use of IVUS will be used to determine the degree of calcium.

3DCT-guided group

Standard of care is angiography guided PCI of the ostium of the RCA. The use of IVUS will be used to determine the degree of calcium.

Angiography-guided group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically indicated non-emergent PCI for an aorta-ostial-RCA lesion defined as a significant de novo lesion \[by angiography or by physiological assessment\] for which the operator intends to fully cover the ostial RCA with stent struts
  • Willing to provide informed consent

You may not qualify if:

  • Emergent PCI indication: if the ostial RCA lesion is the culprit lesion of an acute coronary syndrome \[of note: if the ostial RCA lesion is a non-culprit lesion, patient can be included in the trial\]
  • In-stent restenosis or thrombosis in the ostial RCA
  • Renal insufficiency \[eGFR\<30 ml/min\]
  • Known allergic reaction to contrast medium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ziekenhuis Oost-Limburg

Genk, Limburg, 3600, Belgium

Location

Related Publications (2)

  • Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry. Int J Cardiol. 2018 Mar 1;254:53-58. doi: 10.1016/j.ijcard.2017.10.066. Epub 2018 Jan 28.

    PMID: 29407132BACKGROUND
  • van den Buijs DMF, Poels EM, Willems E, Cottens D, Dotremont K, De Leener K, Meekers E, Ferdinande B, Vrolix M, Dens J, Ameloot K. Three-Dimensional CT for Preprocedural Planning of PCI for Ostial Right Coronary Artery Lesions: A Randomized Controlled Pilot Trial. Circ Cardiovasc Interv. 2025 Feb;18(2):e013584. doi: 10.1161/CIRCINTERVENTIONS.123.013584. Epub 2025 Jan 29.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Koen Ameloot, Dr.

    Ziekenhuis Oost-Limburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessor of the IVUS images will be blinded to treatment arm
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective, investigator-initiated, single-centre, randomized-controlled, assessor blinded pilot trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Interventional cardiologist

Study Record Dates

First Submitted

November 24, 2021

First Posted

December 29, 2021

Study Start

January 13, 2022

Primary Completion

February 8, 2023

Study Completion

February 8, 2023

Last Updated

March 29, 2023

Record last verified: 2023-03

Locations